Transcriptomic profiling and validation of early onset estrogen receptor-positive breast cancer patients

Early-onset breast cancer (≤45 years) is an area of debate due to the adverse clinicopathological features and the unfavourable clinical outcomes observed in earlyonset patients compared to late-onset patients (> 45 years). The present study compared the clinicopathological features of early a...

Full description